Thor Medical ASA (OSL:TRMED) 3-Year EBITDA Growth Rate : 83.00% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA 3-Year EBITDA Growth Rate?

Thor Medical ASA's EBITDA per Share for the three months ended in Dec. 2023 was kr0.00.

During the past 12 months, Thor Medical ASA's average EBITDA Per Share Growth Rate was -128.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 83.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Thor Medical ASA was 83.00% per year. The lowest was -101.00% per year. And the median was -15.10% per year.

Competitive Comparison of Thor Medical ASA's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Thor Medical ASA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's 3-Year EBITDA Growth Rate falls into.

Thor Medical ASA 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Thor Medical ASA (OSL:TRMED) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Thor Medical ASA 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA (OSL:TRMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSL:TRMED) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

0R6Y:UK 8NN:Germany

Address

Kjelsasveien 168 B, Oslo, NOR, 0884

Website

https://www.nordicnanovector.com

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Thor Medical ASA (OSL:TRMED) Headlines

No Headlines